The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intrauterine Contraceptive Devices (IUCD) Market Research Report 2025
Synopsis
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
The global Intrauterine Contraceptive Devices (IUCD) market was valued at US$ 3186.7 million in 2023 and is anticipated to reach US$ 3824.6 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
North American market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intrauterine Contraceptive Devices (IUCD) include Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive Devices (IUCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive Devices (IUCD).
Report Scope
The Intrauterine Contraceptive Devices (IUCD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intrauterine Contraceptive Devices (IUCD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intrauterine Contraceptive Devices (IUCD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Segment by Type
Non-hormonal
Hormonal
Inert
Segment by Application
T Shapes
V Shapes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intrauterine Contraceptive Devices (IUCD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intrauterine Contraceptive Devices (IUCD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
The global Intrauterine Contraceptive Devices (IUCD) market was valued at US$ 3186.7 million in 2023 and is anticipated to reach US$ 3824.6 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
North American market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intrauterine Contraceptive Devices (IUCD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intrauterine Contraceptive Devices (IUCD) include Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360, Trimedic Supply Network Ltd, Medisafe Distribution Inc, Pace Pharmaceuticals Inc, DKT International and Melbea AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intrauterine Contraceptive Devices (IUCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intrauterine Contraceptive Devices (IUCD).
Report Scope
The Intrauterine Contraceptive Devices (IUCD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intrauterine Contraceptive Devices (IUCD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intrauterine Contraceptive Devices (IUCD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare AG
Teva Pharmaceutical Industries Ltd
Actavis PLC
Medicines360
Trimedic Supply Network Ltd
Medisafe Distribution Inc
Pace Pharmaceuticals Inc
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation
Mona Lisa N.V
Segment by Type
Non-hormonal
Hormonal
Inert
Segment by Application
T Shapes
V Shapes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intrauterine Contraceptive Devices (IUCD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intrauterine Contraceptive Devices (IUCD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intrauterine Contraceptive Devices (IUCD) Market Overview
1.1 Product Overview and Scope of Intrauterine Contraceptive Devices (IUCD)
1.2 Intrauterine Contraceptive Devices (IUCD) Segment by Type
1.2.1 Global Intrauterine Contraceptive Devices (IUCD) Market Value Comparison by Type (2024-2030)
1.2.2 Non-hormonal
1.2.3 Hormonal
1.2.4 Inert
1.3 Intrauterine Contraceptive Devices (IUCD) Segment by Application
1.3.1 Global Intrauterine Contraceptive Devices (IUCD) Market Value by Application: (2024-2030)
1.3.2 T Shapes
1.3.3 V Shapes
1.3.4 Others
1.4 Global Intrauterine Contraceptive Devices (IUCD) Market Size Estimates and Forecasts
1.4.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue 2019-2030
1.4.2 Global Intrauterine Contraceptive Devices (IUCD) Sales 2019-2030
1.4.3 Global Intrauterine Contraceptive Devices (IUCD) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intrauterine Contraceptive Devices (IUCD) Market Competition by Manufacturers
2.1 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intrauterine Contraceptive Devices (IUCD) Average Price by Manufacturers (2019-2024)
2.4 Global Intrauterine Contraceptive Devices (IUCD) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Product Type & Application
2.7 Intrauterine Contraceptive Devices (IUCD) Market Competitive Situation and Trends
2.7.1 Intrauterine Contraceptive Devices (IUCD) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intrauterine Contraceptive Devices (IUCD) Players Market Share by Revenue
2.7.3 Global Intrauterine Contraceptive Devices (IUCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intrauterine Contraceptive Devices (IUCD) Retrospective Market Scenario by Region
3.1 Global Intrauterine Contraceptive Devices (IUCD) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intrauterine Contraceptive Devices (IUCD) Global Intrauterine Contraceptive Devices (IUCD) Sales by Region: 2019-2030
3.2.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region: 2019-2024
3.2.2 Global Intrauterine Contraceptive Devices (IUCD) Sales by Region: 2025-2030
3.3 Global Intrauterine Contraceptive Devices (IUCD) Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2019-2030
3.3.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2019-2024
3.3.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2025-2030
3.4 North America Intrauterine Contraceptive Devices (IUCD) Market Facts & Figures by Country
3.4.1 North America Intrauterine Contraceptive Devices (IUCD) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2030)
3.4.3 North America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intrauterine Contraceptive Devices (IUCD) Market Facts & Figures by Country
3.5.1 Europe Intrauterine Contraceptive Devices (IUCD) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2030)
3.5.3 Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Market Facts & Figures by Country
3.6.1 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2030)
3.6.3 Asia Pacific Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intrauterine Contraceptive Devices (IUCD) Market Facts & Figures by Country
3.7.1 Latin America Intrauterine Contraceptive Devices (IUCD) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2030)
3.7.3 Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Type (2019-2030)
4.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Type (2019-2024)
4.1.2 Global Intrauterine Contraceptive Devices (IUCD) Sales by Type (2025-2030)
4.1.3 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Type (2019-2030)
4.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2019-2030)
4.2.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2019-2024)
4.2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Type (2025-2030)
4.2.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Type (2019-2030)
4.3 Global Intrauterine Contraceptive Devices (IUCD) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Application (2019-2030)
5.1.1 Global Intrauterine Contraceptive Devices (IUCD) Sales by Application (2019-2024)
5.1.2 Global Intrauterine Contraceptive Devices (IUCD) Sales by Application (2025-2030)
5.1.3 Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Application (2019-2030)
5.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2019-2030)
5.2.1 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2019-2024)
5.2.2 Global Intrauterine Contraceptive Devices (IUCD) Revenue by Application (2025-2030)
5.2.3 Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Application (2019-2030)
5.3 Global Intrauterine Contraceptive Devices (IUCD) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare AG
6.1.1 Bayer Healthcare AG Corporation Information
6.1.2 Bayer Healthcare AG Description and Business Overview
6.1.3 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.1.5 Bayer Healthcare AG Recent Developments/Updates
6.2 Teva Pharmaceutical Industries Ltd
6.2.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.2.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.3 Actavis PLC
6.3.1 Actavis PLC Corporation Information
6.3.2 Actavis PLC Description and Business Overview
6.3.3 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis PLC Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.3.5 Actavis PLC Recent Developments/Updates
6.4 Medicines360
6.4.1 Medicines360 Corporation Information
6.4.2 Medicines360 Description and Business Overview
6.4.3 Medicines360 Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medicines360 Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.4.5 Medicines360 Recent Developments/Updates
6.5 Trimedic Supply Network Ltd
6.5.1 Trimedic Supply Network Ltd Corporation Information
6.5.2 Trimedic Supply Network Ltd Description and Business Overview
6.5.3 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.5.5 Trimedic Supply Network Ltd Recent Developments/Updates
6.6 Medisafe Distribution Inc
6.6.1 Medisafe Distribution Inc Corporation Information
6.6.2 Medisafe Distribution Inc Description and Business Overview
6.6.3 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.6.5 Medisafe Distribution Inc Recent Developments/Updates
6.7 Pace Pharmaceuticals Inc
6.6.1 Pace Pharmaceuticals Inc Corporation Information
6.6.2 Pace Pharmaceuticals Inc Description and Business Overview
6.6.3 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.7.5 Pace Pharmaceuticals Inc Recent Developments/Updates
6.8 DKT International
6.8.1 DKT International Corporation Information
6.8.2 DKT International Description and Business Overview
6.8.3 DKT International Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DKT International Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.8.5 DKT International Recent Developments/Updates
6.9 Melbea AG
6.9.1 Melbea AG Corporation Information
6.9.2 Melbea AG Description and Business Overview
6.9.3 Melbea AG Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Melbea AG Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.9.5 Melbea AG Recent Developments/Updates
6.10 Pregna International Limited
6.10.1 Pregna International Limited Corporation Information
6.10.2 Pregna International Limited Description and Business Overview
6.10.3 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.10.5 Pregna International Limited Recent Developments/Updates
6.11 Ocon Medical Ltd
6.11.1 Ocon Medical Ltd Corporation Information
6.11.2 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Description and Business Overview
6.11.3 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.11.5 Ocon Medical Ltd Recent Developments/Updates
6.12 SMB Corporation
6.12.1 SMB Corporation Corporation Information
6.12.2 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Description and Business Overview
6.12.3 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 SMB Corporation Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.12.5 SMB Corporation Recent Developments/Updates
6.13 Mona Lisa N.V
6.13.1 Mona Lisa N.V Corporation Information
6.13.2 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Description and Business Overview
6.13.3 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Product Portfolio
6.13.5 Mona Lisa N.V Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intrauterine Contraceptive Devices (IUCD) Industry Chain Analysis
7.2 Intrauterine Contraceptive Devices (IUCD) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intrauterine Contraceptive Devices (IUCD) Production Mode & Process
7.4 Intrauterine Contraceptive Devices (IUCD) Sales and Marketing
7.4.1 Intrauterine Contraceptive Devices (IUCD) Sales Channels
7.4.2 Intrauterine Contraceptive Devices (IUCD) Distributors
7.5 Intrauterine Contraceptive Devices (IUCD) Customers
8 Intrauterine Contraceptive Devices (IUCD) Market Dynamics
8.1 Intrauterine Contraceptive Devices (IUCD) Industry Trends
8.2 Intrauterine Contraceptive Devices (IUCD) Market Drivers
8.3 Intrauterine Contraceptive Devices (IUCD) Market Challenges
8.4 Intrauterine Contraceptive Devices (IUCD) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intrauterine Contraceptive Devices (IUCD) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Intrauterine Contraceptive Devices (IUCD) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Intrauterine Contraceptive Devices (IUCD) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Intrauterine Contraceptive Devices (IUCD) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Intrauterine Contraceptive Devices (IUCD) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Intrauterine Contraceptive Devices (IUCD) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Intrauterine Contraceptive Devices (IUCD), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Product Type & Application
Table 12. Global Key Manufacturers of Intrauterine Contraceptive Devices (IUCD), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intrauterine Contraceptive Devices (IUCD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intrauterine Contraceptive Devices (IUCD) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intrauterine Contraceptive Devices (IUCD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Intrauterine Contraceptive Devices (IUCD) Sales by Region (2019-2024) & (K Units)
Table 18. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Region (2019-2024)
Table 19. Global Intrauterine Contraceptive Devices (IUCD) Sales by Region (2025-2030) & (K Units)
Table 20. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Region (2025-2030)
Table 21. Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Region (2019-2024)
Table 23. Global Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Region (2025-2030)
Table 25. North America Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2024) & (K Units)
Table 27. North America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2025-2030) & (K Units)
Table 28. North America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Intrauterine Contraceptive Devices (IUCD) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Intrauterine Contraceptive Devices (IUCD) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) by Type (2019-2024)
Table 51. Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) by Type (2025-2030)
Table 52. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Type (2019-2024)
Table 53. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Type (2025-2030)
Table 54. Global Intrauterine Contraceptive Devices (IUCD) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Intrauterine Contraceptive Devices (IUCD) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Type (2019-2024)
Table 57. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Type (2025-2030)
Table 58. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) by Application (2019-2024)
Table 61. Global Intrauterine Contraceptive Devices (IUCD) Sales (K Units) by Application (2025-2030)
Table 62. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Application (2019-2024)
Table 63. Global Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Application (2025-2030)
Table 64. Global Intrauterine Contraceptive Devices (IUCD) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Intrauterine Contraceptive Devices (IUCD) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Application (2019-2024)
Table 67. Global Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Application (2025-2030)
Table 68. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Application (2025-2030)
Table 70. Bayer Healthcare AG Corporation Information
Table 71. Bayer Healthcare AG Description and Business Overview
Table 72. Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Healthcare AG Intrauterine Contraceptive Devices (IUCD) Product
Table 74. Bayer Healthcare AG Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd Corporation Information
Table 76. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Pharmaceutical Industries Ltd Intrauterine Contraceptive Devices (IUCD) Product
Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 80. Actavis PLC Corporation Information
Table 81. Actavis PLC Description and Business Overview
Table 82. Actavis PLC Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Actavis PLC Intrauterine Contraceptive Devices (IUCD) Product
Table 84. Actavis PLC Recent Developments/Updates
Table 85. Medicines360 Corporation Information
Table 86. Medicines360 Description and Business Overview
Table 87. Medicines360 Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Medicines360 Intrauterine Contraceptive Devices (IUCD) Product
Table 89. Medicines360 Recent Developments/Updates
Table 90. Trimedic Supply Network Ltd Corporation Information
Table 91. Trimedic Supply Network Ltd Description and Business Overview
Table 92. Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Trimedic Supply Network Ltd Intrauterine Contraceptive Devices (IUCD) Product
Table 94. Trimedic Supply Network Ltd Recent Developments/Updates
Table 95. Medisafe Distribution Inc Corporation Information
Table 96. Medisafe Distribution Inc Description and Business Overview
Table 97. Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Medisafe Distribution Inc Intrauterine Contraceptive Devices (IUCD) Product
Table 99. Medisafe Distribution Inc Recent Developments/Updates
Table 100. Pace Pharmaceuticals Inc Corporation Information
Table 101. Pace Pharmaceuticals Inc Description and Business Overview
Table 102. Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Pace Pharmaceuticals Inc Intrauterine Contraceptive Devices (IUCD) Product
Table 104. Pace Pharmaceuticals Inc Recent Developments/Updates
Table 105. DKT International Corporation Information
Table 106. DKT International Description and Business Overview
Table 107. DKT International Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. DKT International Intrauterine Contraceptive Devices (IUCD) Product
Table 109. DKT International Recent Developments/Updates
Table 110. Melbea AG Corporation Information
Table 111. Melbea AG Description and Business Overview
Table 112. Melbea AG Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Melbea AG Intrauterine Contraceptive Devices (IUCD) Product
Table 114. Melbea AG Recent Developments/Updates
Table 115. Pregna International Limited Corporation Information
Table 116. Pregna International Limited Description and Business Overview
Table 117. Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Pregna International Limited Intrauterine Contraceptive Devices (IUCD) Product
Table 119. Pregna International Limited Recent Developments/Updates
Table 120. Ocon Medical Ltd Corporation Information
Table 121. Ocon Medical Ltd Description and Business Overview
Table 122. Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Ocon Medical Ltd Intrauterine Contraceptive Devices (IUCD) Product
Table 124. Ocon Medical Ltd Recent Developments/Updates
Table 125. SMB Corporation Corporation Information
Table 126. SMB Corporation Description and Business Overview
Table 127. SMB Corporation Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. SMB Corporation Intrauterine Contraceptive Devices (IUCD) Product
Table 129. SMB Corporation Recent Developments/Updates
Table 130. Mona Lisa N.V Corporation Information
Table 131. Mona Lisa N.V Description and Business Overview
Table 132. Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Mona Lisa N.V Intrauterine Contraceptive Devices (IUCD) Product
Table 134. Mona Lisa N.V Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Intrauterine Contraceptive Devices (IUCD) Distributors List
Table 138. Intrauterine Contraceptive Devices (IUCD) Customers List
Table 139. Intrauterine Contraceptive Devices (IUCD) Market Trends
Table 140. Intrauterine Contraceptive Devices (IUCD) Market Drivers
Table 141. Intrauterine Contraceptive Devices (IUCD) Market Challenges
Table 142. Intrauterine Contraceptive Devices (IUCD) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intrauterine Contraceptive Devices (IUCD)
Figure 2. Global Intrauterine Contraceptive Devices (IUCD) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Intrauterine Contraceptive Devices (IUCD) Market Share by Type in 2023 & 2030
Figure 4. Non-hormonal Product Picture
Figure 5. Hormonal Product Picture
Figure 6. Inert Product Picture
Figure 7. Global Intrauterine Contraceptive Devices (IUCD) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Intrauterine Contraceptive Devices (IUCD) Market Share by Application in 2023 & 2030
Figure 9. T Shapes
Figure 10. V Shapes
Figure 11. Others
Figure 12. Global Intrauterine Contraceptive Devices (IUCD) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intrauterine Contraceptive Devices (IUCD) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Intrauterine Contraceptive Devices (IUCD) Sales (2019-2030) & (K Units)
Figure 15. Global Intrauterine Contraceptive Devices (IUCD) Average Price (USD/Unit) & (2019-2030)
Figure 16. Intrauterine Contraceptive Devices (IUCD) Report Years Considered
Figure 17. Intrauterine Contraceptive Devices (IUCD) Sales Share by Manufacturers in 2023
Figure 18. Global Intrauterine Contraceptive Devices (IUCD) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Intrauterine Contraceptive Devices (IUCD) Players: Market Share by Revenue in 2023
Figure 20. Intrauterine Contraceptive Devices (IUCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Intrauterine Contraceptive Devices (IUCD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Country (2019-2030)
Figure 23. North America Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Country (2019-2030)
Figure 27. Europe Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Region (2019-2030)
Figure 35. China Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Country (2019-2030)
Figure 46. Latin America Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Intrauterine Contraceptive Devices (IUCD) Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Intrauterine Contraceptive Devices (IUCD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Intrauterine Contraceptive Devices (IUCD) by Type (2019-2030)
Figure 56. Global Revenue Market Share of Intrauterine Contraceptive Devices (IUCD) by Type (2019-2030)
Figure 57. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Intrauterine Contraceptive Devices (IUCD) by Application (2019-2030)
Figure 59. Global Revenue Market Share of Intrauterine Contraceptive Devices (IUCD) by Application (2019-2030)
Figure 60. Global Intrauterine Contraceptive Devices (IUCD) Price (USD/Unit) by Application (2019-2030)
Figure 61. Intrauterine Contraceptive Devices (IUCD) Value Chain
Figure 62. Intrauterine Contraceptive Devices (IUCD) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
